Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Double 5-FU modulation with folinic acid and recombinant alfa2b-Interferon : a phase I–II study in metastatic colorectal cancer patients
5-Fluorouracil (5-FU) is the most widely employed chemotherapeutic agent for patients with metastatic colorectal cancer (MCC) and objective response rates (ORR) are achievable in approximately 10–20 Wo of trea...